PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 3, 2026Frontiers in Immunology0 citationsOpen Access

Combined assessment of 25(OH)D, CD4+/CD8+ ratio, and prognostic nutritional index for anti-dsDNA-based stratification in systemic lupus erythematosus

CYChaoju YangJMJuntao MengNDNan Ding

Key Points

  • The study aims to explore the relationships between 25(OH)D, CD4+/CD8+ ratio, and prognostic nutritional index with anti-dsDNA antibody titers in SLE.
  • Enrolled 126 patients with systemic lupus erythematosus (SLE) classified as anti-dsDNA-negative or positive.
  • Patients were stratified by anti-dsDNA titer into low-titer and high-titer groups.
  • Performed receiver operating characteristic curve analysis for biomarker performance evaluation.
  • Anti-dsDNA-positive patients showed significantly lower 25(OH)D, CD4+/CD8+ ratio, and PNI than anti-dsDNA-negative patients (P<0.05).
  • Combined assessment provided better discrimination for anti-dsDNA titers compared to PNI and C3.
  • 25(OH)D demonstrated the highest AUC among individual biomarkers for anti-dsDNA serostatus.

Abstract

Background Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease in which anti-double-stranded DNA (anti-dsDNA) antibodies are closely associated with disease activity and organ involvement. However, the relationships of 25-hydroxyvitamin D 25(OH)D, CD4 + /CD8 + ratio, and prognostic nutritional index (PNI) with anti-dsDNA antibody status and titer stratification remain incompletely understood. Methods A total of 126 patients with SLE were enrolled and classified into an anti-dsDNA-negative group and an anti-dsDNA-positive group. According to anti-dsDNA titers, patients were further stratified into low-titer and high-titer groups. Clinical characteristics and laboratory parameters, including 25(OH)D, CD4 + /CD8 + ratio, and PNI, were compared among groups. Receiver operating characteristic curve analysis was performed to evaluate the discriminatory performance of 25(OH)D, CD4 + /CD8 + ratio, PNI, and their combined model. Results Compared with anti-dsDNA-negative patients, anti-dsDNA-positive patients had significantly lower levels of C3, C4, the CD4 + /CD8 + ratio, 25(OH)D, and PNI, together with a higher prevalence of renal involvement (all P 0.05). Significant differences in 25(OH)D, the CD4 + /CD8 + ratio, and PNI were also observed across the anti-dsDNA-negative, low-positive, and high-positive groups. In ROC analysis, 25(OH)D showed the highest AUC among the individual biomarkers for anti-dsDNA serostatus, whereas the combined assessment achieved the highest overall AUC. For stratifying low-positive from high-positive anti-dsDNA titers, the combined assessment showed better discriminatory performance than PNI and C3. Conclusions Combined assessment of 25(OH)D, the CD4 + /CD8 + ratio, and PNI may provide complementary value for anti-dsDNA-based stratification in SLE. Its performance was comparable to C3 for anti-dsDNA serostatus and superior to C3 for stratifying low-from high-positive anti-dsDNA titers. These findings should be considered exploratory and require validation in external cohorts.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yang et al. (2026) studied this question.

synapsesocial.com/papers/69f6e62e8071d4f1bdfc6c54https://doi.org/10.3389/fimmu.2026.1841620
Ask AI
Helpful
Bookmark
Share
View Full Paper